Business News/Market/Market Stats/   Sun Pharmaceutical Industries share price
Mutual Fund Ownership
Ownership as on: Sat, 23 Sep, 2023

ICICI Prudential Exports and Services Fund Growth

NA
Equity
Amount Invested (Cr.)88.09
% of AUM7.98%

Quant Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)9.90
% of AUM7.20%

Invesco India Equity Savings Fund Regular Growth

2/5
Hybrid
Amount Invested (Cr.)9.58
% of AUM7.14%

ICICI Prudential India Opportunities Fund Regular Growth

NA
Equity
Amount Invested (Cr.)795.29
% of AUM7.04%

ICICI Prudential Bharat Consumption Fund Regular Cumulative

NA
Equity
Amount Invested (Cr.)147.61
% of AUM6.93%

Sun Pharmaceutical Industries SUMMARY

Sun Pharmaceutical Industries is trading -1.26% lower at Rs 1131.60 as compared to its last closing price. Sun Pharmaceutical Industries has been trading in the price range of 1145.45 & 1128.75. Sun Pharmaceutical Industries has given 14.45% in this year & -0.23% in the last 5 days.

 

Sun Pharmaceutical Industries has TTM P/E ratio 29.95 as compared to the sector P/E of 21.00.There are 35 analysts who have initiated coverage on Sun Pharmaceutical Industries. There are 17 analysts who have given it a strong buy rating & 16 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.

 

The company posted a net profit of 2022.54 Crores in its last quarter.

 

Listed peers of Sun Pharmaceutical Industries include Sun Pharmaceutical Industries (-1.26%), Divis Laboratories (-0.96%), Cipla (-1.89%) etc.

FAQs about Sun Pharmaceutical Industries share price

Sun Pharmaceutical Industries is trading at 1131.60 as on Fri Sep 22 2023 10:18:39. This is -1.26% lower as compared to its previous closing price of 1146.00.

The market capitalization of Sun Pharmaceutical Industries is 271508.75 Cr as on Fri Sep 22 2023 10:18:39.

The average broker rating on Sun Pharmaceutical Industries is Strong Buy. The breakup of analyst rating is given below -

  • 17 analysts have given a strong buy rating
  • 16 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Sun Pharmaceutical Industries is 1169.90 whereas the 52 wk low is 856.85

Sun Pharmaceutical Industries can be analyzed on the following key metrics -

  • TTM P/E: 29.95
  • Sector P/E: 21.00
  • Dividend Yield: 1.00%
  • D/E ratio: -

Sun Pharmaceutical Industries reported a net profit of 8473.58 Cr in 2023.

Recommended For You
Trending Stocks
1452.75+41.20(2.92%)
10536.45+240.45(2.34%)
418.65-9.95 (-2.32%)
1529.20-24.40 (-1.57%)